Free Trial

Privia Health Group, Inc. (NASDAQ:PRVA) Stake Lifted by XTX Topco Ltd

Privia Health Group logo with Medical background

XTX Topco Ltd increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 232.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 33,303 shares of the company's stock after purchasing an additional 23,282 shares during the period. XTX Topco Ltd's holdings in Privia Health Group were worth $651,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. First Horizon Advisors Inc. grew its position in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock worth $35,000 after acquiring an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after acquiring an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. bought a new stake in shares of Privia Health Group in the 4th quarter valued at $51,000. Quadrant Capital Group LLC grew its position in Privia Health Group by 11.8% in the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock valued at $95,000 after purchasing an additional 511 shares during the period. Finally, Nisa Investment Advisors LLC grew its position in Privia Health Group by 185.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company's stock valued at $98,000 after purchasing an additional 3,249 shares during the period. 94.48% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

PRVA has been the subject of several recent analyst reports. Needham & Company LLC reiterated a "buy" rating and issued a $30.00 target price on shares of Privia Health Group in a research note on Thursday, April 10th. Canaccord Genuity Group upped their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a report on Friday, February 28th. Truist Financial increased their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a report on Thursday, April 10th. JMP Securities set a $29.00 target price on shares of Privia Health Group in a research report on Friday, February 28th. Finally, Stephens reaffirmed an "overweight" rating and set a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $27.14.

Read Our Latest Analysis on Privia Health Group

Privia Health Group Stock Up 0.6 %

NASDAQ:PRVA traded up $0.15 during trading hours on Thursday, reaching $23.54. 117,161 shares of the company's stock were exchanged, compared to its average volume of 776,521. The firm has a market capitalization of $2.86 billion, a price-to-earnings ratio of 235.57, a P/E/G ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $26.04. The company has a 50-day moving average of $23.72 and a 200 day moving average of $21.78.

Insiders Place Their Bets

In other news, CFO David Mountcastle sold 5,630 shares of the firm's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the sale, the chief financial officer now owns 179,676 shares in the company, valued at $4,021,148.88. This trade represents a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 10.70% of the stock is currently owned by insiders.

Privia Health Group Company Profile

(Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

See Also

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Should You Invest $1,000 in Privia Health Group Right Now?

Before you consider Privia Health Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.

While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines